Literature DB >> 31130079

Antimicrobial treatment of Stenotrophomonas maltophilia invasive infections: Systematic review.

Marija V Anđelković1, Slobodan M Janković2, Marina J Kostić2, Radica S Živković Zarić2, Valentina D Opančina2, Miloš Ž Živić3, Marko J Milosavljević3, Ana V Pejčić2.   

Abstract

Stenotrophomonas maltophilia can cause serious infections in immunocompromised patients. The aim of this systematic review was to establish what invasive infections in humans are caused by S. maltophilia and to evaluate the optimal choice of antibiotics for their treatment. MEDLINE, EBSCO, SCOPUS, SCINDEKS and GOOGLE SCHOLAR were systematically searched for clinical trials, observational studies, case reports or case series describing invasive infections with S. maltophilia in patients of any age. S. maltophilia may cause invasive infections of various tissues in hospitalized patients. In the great majority of cases it was susceptible to co-trimoxazole, levofloxacin and ceftazidime. In about three fourths of the cases, the treatment was successful, while less than 20% of the patients died. S. maltophilia is increasingly associated with serious invasive infections in hospitalized patients and due to growing trend of resistance to almost all antibiotics requires a careful approach to patients who is harboring this bacterium.

Entities:  

Keywords:  antibiotic treatment; invasive infections; systematic review

Mesh:

Substances:

Year:  2019        PMID: 31130079     DOI: 10.1080/1120009X.2019.1620405

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  6 in total

1.  Trimethoprim-Sulfamethoxazole Versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals.

Authors:  Sadia H Sarzynski; Sarah Warner; Junfeng Sun; Roland Matsouaka; John P Dekker; Ahmed Babiker; Willy Li; Yi Ling Lai; Robert L Danner; Vance G Fowler; Sameer S Kadri
Journal:  Open Forum Infect Dis       Date:  2022-01-17       Impact factor: 3.835

Review 2.  Clinical challenges treating Stenotrophomonas maltophilia infections: an update.

Authors:  Maria F Mojica; Romney Humphries; John J Lipuma; Amy J Mathers; Gauri G Rao; Samuel A Shelburne; Derrick E Fouts; David Van Duin; Robert A Bonomo
Journal:  JAC Antimicrob Resist       Date:  2022-05-05

3.  In vitro Antibacterial Activity and Resistance Prevention of Antimicrobial Combinations for Dihydropteroate Synthase-Carrying Stenotrophomonas maltophilia.

Authors:  Jin Zhao; Yan Huang; Jian Li; Bo Zhang; Zhiwei Dong; Dong Wang
Journal:  Infect Drug Resist       Date:  2022-06-13       Impact factor: 4.177

4.  The Contribution of Efflux Systems to Levofloxacin Resistance in Stenotrophomonas maltophilia Clinical Strains Isolated in Warsaw, Poland.

Authors:  Olga M Zając; Stefan Tyski; Agnieszka E Laudy
Journal:  Biology (Basel)       Date:  2022-07-12

5.  Advances in the Microbiology of Stenotrophomonas maltophilia.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2021-05-26       Impact factor: 50.129

6.  Phenotypic and Molecular Characteristics of the MDR Efflux Pump Gene-Carrying Stenotrophomonas maltophilia Strains Isolated in Warsaw, Poland.

Authors:  Olga M Zając; Stefan Tyski; Agnieszka E Laudy
Journal:  Biology (Basel)       Date:  2022-01-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.